Ulipristal acetate: An update for Australian GPs

Research output: Contribution to journalArticleOtherpeer-review

4 Citations (Scopus)


Background In Australia, use and understanding of emergency contraception among women remains relatively low. This is despite the introduction of levonorgestrel emergency contraceptive pills (ECPs) more than a decade ago. In April 2016, a new ECP with the active ingredient ulipristal acetate became available in Australia. Objectives The aims of this article are to increase understanding of the recently introduced ulipristal acetate ECP, including its safety profile, efficacy and special considerations; dispel common myths and misconceptions about emergency contraception; and to provide guidance on emergency contraceptive management in general practice, considering the recent advances. Discussion Women are more receptive to information about emergency contraception that has been provided by a general practitioner (GP). As such, the availability of the ulipristal acetate ECP in Australia provides an important opportunity for GPs to help women prevent unplanned pregnancies.

Original languageEnglish
Pages (from-to)301 - 304
Number of pages4
JournalAustralian Family Physician
Issue number5
Publication statusPublished - 1 May 2017

Cite this